These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37790500)

  • 1. Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus Inoculum.
    Ibaraki M; Lai L; Huerta C; Natrajan MS; Collins MH; Anderson EJ; Mulligan MJ; Rouphael N; Moe CL; Liu P
    Res Sq; 2023 Sep; ():. PubMed ID: 37790500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus Inoculum.
    Ibaraki M; Lai L; Huerta C; Natrajan MS; Collins MH; Anderson EJ; Mulligan MJ; Rouphael N; Moe CL; Liu P
    Arch Microbiol Immunol; 2023; 7(4):318-325. PubMed ID: 38707746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
    Swanstrom J; Lindesmith LC; Donaldson EF; Yount B; Baric RS
    J Virol; 2014 Jan; 88(2):829-37. PubMed ID: 24173225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.
    Rouphael N; Beck A; Kirby AE; Liu P; Natrajan MS; Lai L; Phadke V; Winston J; Raabe V; Collins MH; Girmay T; Alvarez A; Beydoun N; Karmali V; Altieri-Rivera J; Lindesmith LC; Anderson EJ; Wang Y; El-Khorazaty J; Petrie C; Baric RS; Baqar S; Moe CL; Mulligan MJ
    J Infect Dis; 2022 Nov; 226(10):1771-1780. PubMed ID: 35137154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of a household norovirus outbreak occurred in Valencia (Spain).
    Carmona-Vicente N; Fernández-Jiménez M; Vila-Vicent S; Rodríguez-Díaz J; Buesa J
    BMC Infect Dis; 2016 Mar; 16():124. PubMed ID: 26968797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity following Snow Mountain virus challenge.
    Lindesmith L; Moe C; Lependu J; Frelinger JA; Treanor J; Baric RS
    J Virol; 2005 Mar; 79(5):2900-9. PubMed ID: 15709009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity.
    Czakó R; Atmar RL; Opekun AR; Gilger MA; Graham DY; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):221-8. PubMed ID: 25540269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells.
    Carmona-Vicente N; Allen DJ; Rodríguez-Díaz J; Iturriza-Gómara M; Buesa J
    Virol J; 2016 May; 13():82. PubMed ID: 27206610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological Correlates of Protection against a GII.4 Norovirus.
    Atmar RL; Bernstein DI; Lyon GM; Treanor JJ; Al-Ibrahim MS; Graham DY; Vinjé J; Jiang X; Gregoricus N; Frenck RW; Moe CL; Chen WH; Ferreira J; Barrett J; Opekun AR; Estes MK; Borkowski A; Baehner F; Goodwin R; Edmonds A; Mendelman PM
    Clin Vaccine Immunol; 2015 Aug; 22(8):923-9. PubMed ID: 26041041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus.
    van Loben Sels JM; Meredith LW; Sosnovtsev SV; de Graaf M; Koopmans MPG; Lindesmith LC; Baric RS; Green KY; Goodfellow IG
    J Virol Methods; 2021 Nov; 297():114196. PubMed ID: 34019938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses.
    Lindesmith LC; Beltramello M; Swanstrom J; Jones TA; Corti D; Lanzavecchia A; Baric RS
    Open Forum Infect Dis; 2015 Sep; 2(3):ofv084. PubMed ID: 26180833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus.
    Treanor JJ; Jiang X; Madore HP; Estes MK
    J Clin Microbiol; 1993 Jun; 31(6):1630-4. PubMed ID: 8391025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.
    Cannon JL; Lindesmith LC; Donaldson EF; Saxe L; Baric RS; Vinjé J
    J Virol; 2009 Jun; 83(11):5363-74. PubMed ID: 19297483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
    Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.